Pictet Asset Management (UK)’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$61.9M Buy
252,550
+31,009
+14% +$8.14M 0.07% 307
2021
Q1
$58.7M Buy
221,541
+93,326
+73% +$26.3M 0.07% 302
2020
Q4
$37.6M Buy
128,215
+125,615
+4,831% +$32.2M 0.05% 362
2020
Q3
$615K Buy
2,600
+1,400
+117% +$318K ﹤0.01% 1032
2020
Q2
$238K Buy
+1,200
New +$224K ﹤0.01% 1049

Other funds holding AMED

Pictet Asset Management (UK)'s AMED Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Amedisys (AMED) stake by 14% in Q2 2021, buying an estimated $8.14M and bringing the position to 252,550 shares worth $61.9M. The position accounts for 0.07% of the portfolio, ranked #307.

Pictet Asset Management (UK) first reported a position in AMED in Q2 2020 and has held it in 5 quarters since. 375 funds tracked by Wall St. Rank hold AMED as of Q2 2021.

  • Pictet Asset Management (UK) held 252,550 shares of Amedisys worth $61.9M as of Q2 2021.
  • Pictet Asset Management (UK) bought 31,009 Amedisys shares in Q2 2021, an estimated $8.14M.
  • Amedisys made up 0.07% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #307 holding.
  • Pictet Asset Management (UK) first reported a position in Amedisys in Q2 2020 and has held it in 5 quarters since.
  • 375 funds tracked by Wall St. Rank held Amedisys as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.